Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Miguel Martin Abelleyro"'
Autor:
María Sol Ruiz, María Sol Anchordoqui, Leandro German Gutierrez, Miguel Martin Abelleyro, Josefina Freitas, Irene Larripa, Michele Bianchini, Carlos Daniel de Brasi
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:e449-e453
Autor:
Maricel F. Molina, Sofia Siffo, Ezequiela Adrover, Héctor M. Targovnik, Miguel Martin Abelleyro, Karen G. Scheps, Mauricio Gomes Pio, Carina M. Rivolta
Publikováno v:
Molecular and cellular endocrinology. 534
Thyroglobulin (TG) is a large glycosylated protein of 2767 amino acids, secreted by the thyrocytes into the follicular lumen. It plays an essential role in the process of thyroid hormone synthesis. TG gene variants lead to permanent congenital hypoth
Autor:
Claudia Pamela Radic, Miguel Martin Abelleyro, Vanina Daniela Marchione, Tomás Tetzlaff, Karen Waisman, D. Neme, Liliana Carmen Rossetti, Carlos Daniel de Brasi
Publikováno v:
Human mutationREFERENCES. 41(4)
Hemophilia A (HA) provides excellent models to analyze genotype-phenotype relationships and mutational mechanisms. NhF8ld's breakpoints were characterized using case-specific DNA-tags, direct- or inverse-polymerase chain reaction amplification, and S
Autor:
Vanina Daniela Marchione, Enrique Medina-Acosta, Miguel Martin Abelleyro, Micaela Palmitelli, Claudia Pamela Radic, Carlos Daniel de Brasi, Liliana Carmen Rossetti, Irene Larripa, D. Neme
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Among other applications of long-distance haplotype phasing in clinical genetics, determination of linked DNA markers as surrogate for problematic structural variants (e.g., repeat-mediated rearrangements) is essential to perform diagnosis from low-q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a1782c9b04f11f9dbcf029b79aa974
https://europepmc.org/articles/PMC6460640/
https://europepmc.org/articles/PMC6460640/
Autor:
Maria de Los Angeles Curto, Claudia Pamela Radic, Liliana Carmen Rossetti, Miguel Martin Abelleyro, Carlos Daniel de Brasi, Vanina Daniela Marchione
Publikováno v:
Thrombosis and Haemostasis. 115:678-681
F8 intron 22 inversions (INV22), the commonest cause of severe haemophilia A (HA), are mostly represented by type I (INV22-1) and type II (INV22-2) patterns (4:1) using BclI-fragments´ based techniques such as inverse shifting-PCR (IS-PCR/2008). Usi
Autor:
María Micaela Carcione, Carlos Daniel de Brasi, Liliana Francipane, Julián Nevado, Pablo Lapunzina, Irena Szijan, Leonela Natalia Luce, Miguel Martin Abelleyro, Chiara Mazzanti, Liliana Carmen Rossetti, Florencia Giliberto, Sebastián Menazzi, Claudia Pamela Radic
Publikováno v:
Neuromuscular Disorders. 29:S170-S171
Fil: Luce, Leonela Natalia. Universidad de Buenos Aires. Facultad de Farmacia y Bioquimica. Departamento de Microbiologia, Inmunologia y Biotecnologia. Catedra de Genetica y Biologia Molecular; Argentina. Consejo Nacional de Investigaciones Cientific
Autor:
Miguel Martin Abelleyro, Irene Larripa, Liliana Carmen Rossetti, Carlos Daniel de Brasi, Claudia Pamela Radic
Publikováno v:
International Journal of Molecular Sciences, Vol 12, Iss 10, Pp 7271-7285 (2011)
International Journal of Molecular Sciences
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
International Journal of Molecular Sciences
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The factor VIII gene (F8) intron 22 inversion (Inv22) is a paradigmatic duplicon-mediated rearrangement, found in about one half of patients with severe hemophilia A worldwide. The identification of this prevalent cause of hemophilia was delayed for
Autor:
Irene Larripa, M. Candela, Claudia Pamela Radic, Liliana Carmen Rossetti, Carlos Daniel de Brasi, Miguel Martin Abelleyro
Publikováno v:
Annals of Hematology. 91:633-636
Dear Editor, Hemophilia A (HA) (OMIM 306700) is an X-linked inherited bleeding disorder caused by deleterious mutations in the coagulation factor VIII gene (F8). Even though there is a broad diversity of HA-causative mutations, an uncommon type of re
Autor:
I. Szurkalo, L. C. Rossetti, Miguel Martin Abelleyro, Raúl Pérez Bianco, L. Primiani, C. P. Radic, M. de Tezanos Pinto, D. Neme, M. Candela, I. B. Larripa, C. D. De Brasi
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 19(4)
Inhibitor development against exogenous factor VIII is a severe impairment of replacement therapy affecting 18% of Argentine patients with severe haemophilia A (HA). To study the molecular predisposition for inhibitor development, we genotyped 260 HA
Autor:
Irene Larripa, Raúl Pérez Bianco, Liliana Carmen Rossetti, Anne Goodeve, M. Candela, Claudia Pamela Radic, Miguel de Tezanos Pinto, Carlos Daniel de Brasi, Miguel Martin Abelleyro
In haemophilia B (HB) (factor IX [FIX] deficiency), F9 genotype largely determines clinical phenotype. Aimed to characterise Argentinian families with HB, this study presents F9 genotype frequencies and their specific FIX inhibitor risk and 10 novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a640486cf9ca77a8310327884a43abfc
https://europepmc.org/articles/PMC4220540/
https://europepmc.org/articles/PMC4220540/